| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 200,596 | 223,230 | 284,399 | | Cost of Revenue | 188,108 | 201,046 | 248,065 | | | Gross Profit | 12,488 | 22,184 | 36,334 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 16,889 | 29,507 | 29,143 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,401) | (7,323) | 7,191 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 385 | 110 | 1,030 | | Earnings Before Interest And Taxes | (4,016) | (7,213) | 8,221 | | Interest Expense | 257 | 440 | 1,084 | | Income Before Tax | (4,273) | (7,653) | 7,137 | | Income Tax Expense | (90) | 1,427 | 3,679 | | Minority Interest |
-
| 59 |
-
| | | | Net Income From Continuing Ops | (4,183) | (9,021) | 3,458 | | | Non-recurring Events | | Discontinued Operations | (634) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,817) | (9,021) | 3,458 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,817) | ($9,021) | $3,458 |
|
0.29% Nasdaq 
Income Statement
